TY - JOUR
T1 - Conduction disturbances after transcatheter aortic valve implantation
AU - Maznyczka, Annette
AU - Pilgrim, Thomas
AU - Philippon, François
AU - Rodés-Cabau, Josep
AU - De Backer, Ole
N1 - © The Author(s) 2026. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For commercial re-use, please contact [email protected] for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact [email protected].
PY - 2026/2/19
Y1 - 2026/2/19
N2 - Conduction disturbances and permanent pacemaker implantation remain the most common complications after transcatheter aortic valve implantation. The strongest predictors of conduction abnormalities and subsequent permanent pacemaker implantation after transcatheter aortic valve implantation include pre-existing right bundle branch block, a short membranous interventricular septum, deep transcatheter heart valve implantation, and valve type. Importantly, both new permanent pacemaker implantation and new left bundle branch block after transcatheter aortic valve implantation are associated with increased mortality and heart failure hospitalizations. As transcatheter aortic valve indications expand to lower risk and younger populations, with longer life expectancy, strategies to minimize the risk of conduction disturbances and optimize their detection and management become increasingly crucial. Refined transcatheter heart valve implantation techniques may be associated with a reduction in rhythm disturbances after transcatheter aortic valve implantation and anti-inflammatory treatments are under investigation. Ongoing trials are investigating the impact of beta-blocker withdrawal to prevent conduction abnormalities, electrophysiology studies for risk stratification, and conduction system pacing to prevent adverse cardiac remodelling. This review aims to provide an overview of the incidence, pathophysiology, and consequences of conduction disturbances after transcatheter aortic valve implantation, discuss preventive strategies, highlight the relevant ongoing studies, and provide an evidence-based framework for the management of this important clinical issue.
AB - Conduction disturbances and permanent pacemaker implantation remain the most common complications after transcatheter aortic valve implantation. The strongest predictors of conduction abnormalities and subsequent permanent pacemaker implantation after transcatheter aortic valve implantation include pre-existing right bundle branch block, a short membranous interventricular septum, deep transcatheter heart valve implantation, and valve type. Importantly, both new permanent pacemaker implantation and new left bundle branch block after transcatheter aortic valve implantation are associated with increased mortality and heart failure hospitalizations. As transcatheter aortic valve indications expand to lower risk and younger populations, with longer life expectancy, strategies to minimize the risk of conduction disturbances and optimize their detection and management become increasingly crucial. Refined transcatheter heart valve implantation techniques may be associated with a reduction in rhythm disturbances after transcatheter aortic valve implantation and anti-inflammatory treatments are under investigation. Ongoing trials are investigating the impact of beta-blocker withdrawal to prevent conduction abnormalities, electrophysiology studies for risk stratification, and conduction system pacing to prevent adverse cardiac remodelling. This review aims to provide an overview of the incidence, pathophysiology, and consequences of conduction disturbances after transcatheter aortic valve implantation, discuss preventive strategies, highlight the relevant ongoing studies, and provide an evidence-based framework for the management of this important clinical issue.
U2 - 10.1093/eurheartj/ehag093
DO - 10.1093/eurheartj/ehag093
M3 - Journal article
C2 - 41712363
SN - 1522-9645
JO - European Heart Journal
JF - European Heart Journal
ER -